BRCA1 mRNA levels following a 4–6-week intervention with oral 3,3′-diindolylmethane

BACKGROUND: Haploinsufficiency may contribute to the development of breast cancer among women with a BRCA1 mutation. Thus, interventions that enhance BRCA1 expression may represent avenues for prevention. Studies have shown that 3,3′-diindolylmethane (DIM) can upregulate BRCA1 expression in breast c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotsopoulos, J, Zhang, S, Akbari, M, Salmena, L, Llacuachaqui, M, Zeligs, M, Sun, P, Narod, S A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183839/
https://www.ncbi.nlm.nih.gov/pubmed/25025957
http://dx.doi.org/10.1038/bjc.2014.391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183839/
https://www.ncbi.nlm.nih.gov/pubmed/25025957
http://dx.doi.org/10.1038/bjc.2014.391

Ejemplares similares